Single agent and combination studies of pralatrexate and molecular correlates of sensitivity.

Br J Cancer · 2011 · PMC3031902 · PMID 21179031

Europe PMC DOI

hedged sentence

0.0830

closest p · 1.7× alpha

0.0830

boldest claim

The sentences

did not reach statistical significanceP =0.083so close (0.05 < p ≤ 0.1)

Pralatrexate-sensitive cells expressed relatively higher levels of DHFR, a target of pralatrexate, than the ‘resistant’ group, but this did not reach statistical significance ( P =0.083, Figure 3A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.